Navigation Links
Medical Study Authors Often Fail to Disclose Industry Ties
Date:9/14/2010

TUESDAY, Sept. 14 (HealthDay News) -- Nearly half of U.S. surgeons who received at least $1 million in payments from companies that make orthopedic devices such as artificial joints did not disclose their financial ties when they published articles on such devices in medical journals, a new study has found.

This means that medical professionals and others who read the articles aren't aware of conflicts of interest that could affect patient care, explained the researchers at the Institute on Medicine as a Profession (IMAP), a think tank at the Columbia University College of Physicians and Surgeons in New York City.

"The findings raise troubling questions about undisclosed payments or royalties and other fees from medical device companies that could lead to biased scientific conclusions," study senior author David Rothman, president of IMAP, said in an institute news release.

Using public databases, he and his colleagues examined 2007 physician payment information from five orthopedic device makers (Biomet, DePuy Orthopaedics, Smith & Nephew, Stryker, and Zimmer) and found that they gave 1,654 payments totaling $248 million for consulting, honoraria and other payments for services.

The researchers also found that 62 percent of the $248 million was given to 41 orthopedic surgeon researchers who received amounts ranging from more than $1 million to $8.8 million.

Of the 95 journal articles published by those 41 highly paid orthopedic consultants after they received their large payments -- nearly all of them about a medical device -- less than half disclosed a financial tie between the author and orthopedic device maker. None of the articles revealed the large amounts of industry money received by the authors, the investigators found.

Consumers should be concerned by the findings, Rothman's team noted in the report published online Sept. 13 in the journal Archives of Internal Medicine.

"Patients have a real stake in transparency. You want to make sure that the surgeon is choosing the device that is best for you and that your doctor is not getting biased information," Rothman said in the news release.

"The next generation of physicians should know that every nickel they take from industry is going to be made public," he added.

Industry-funded medical research -- even when financial ties are transparent --has come under increased scrutiny over the past few months.

A recent review of hundreds of clinical drug trials conducted between 2000 and 2006, for example, found that studies sponsored by the pharmaceutical industry were more likely to publish favorable results than those with no financial interest in the findings.

In addition, a review of 150 recently published stories on children's health found that industry-sponsored trials were at greater risk of distortion than non-profit or government-sponsored studies.

More information

The U.S. National Institute of Environmental Health Sciences has more about research ethics.

-- Robert Preidt

SOURCES: Pediatrics, July 12, 2010; Children's Hospital Boston, news release, August 2, 2010; Institute on Medicine as a Profession, news release, Sept. 13, 2010.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New study: Serious gaps in medical journals disclosure of physician relationships with industry
2. USGI medical tissue anchors show durability beyond 1 year
3. VCU Medical Center leads study of first US portable driver for powering the total artificial heart
4. Research demonstrates benefits of medical cannabis as a treatment for chronic pain
5. Radiologists call for national strategy to address medical imaging overuse
6. NIH renews research program to develop medical countermeasures against radiological, nuclear threats
7. U-Ms efforts to encourage disclosure of medical errors decreased claims
8. How badly does it hurt? Research examines the biomedical diagnosis of pain
9. Speed electronic medical record adoption via key medical centers, says Management Science
10. More Than 70,000 Kids Injured By Medical Devices Each Year
11. Childrens National Medical Center receives first NIH CTSA given to a childrens hospital
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Medical Study Authors Often Fail to Disclose Industry Ties
(Date:12/9/2016)... Harrisburg, PA (PRWEB) , ... December 09, 2016 ... ... concussion education program through the Pennsylvania Cable Network (PCN) during the summer of ... Brain Injury Implementation Grant provided by the United States Department of Health and ...
(Date:12/8/2016)... Pennsylvania (PRWEB) , ... December 08, 2016 , ... ... Duck Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which ... , “This was our first franchise-wide Quack Gives Back initiative, ...
(Date:12/8/2016)... , ... December 08, 2016 , ... CURE Media Group, ... and advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat lung ... announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored to team up ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims ... employees that are both engaging and easy to use. Coming off the heels ... company revealed today its plans to roll out new AI-powered self-service enhancements to ...
(Date:12/8/2016)... Dallas, TX (PRWEB) , ... December 08, 2016 , ... ... to continue to be a convenient service for Texas, they are expanding their presence ... will involve a hiring spree that will bring new jobs to the Dallas and ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... 2016 Research and Markets has announced ... report to their offering. ... The report forecasts the global optical transceiver market to ... The report covers the present scenario and the growth ... the market size, the report considers the revenue generated from the ...
(Date:12/9/2016)... Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged ... rare diseases, today announced that senior management will participate in a ... at the InterContinental Barclay Hotel in New York City ... About aTyr Pharma ... aTyr Pharma is engaged in the discovery ...
(Date:12/9/2016)... 2016  Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced a ... 2b trial evaluating treatment with intepirdine (RVT-101), combined ... plus placebo in people with mild-to-moderate Alzheimer,s disease. ... to treatment was associated with reduced progression in ...
Breaking Medicine Technology: